You are here

$9.89 Billion Cancer Vaccines Market - Global Forecasts from 2019 to 2024

DUBLIN, April 4, 2019 /PRNewswire/ -- The "Cancer Vaccines Market - Forecasts from 2019 to 2024" report has been added to's offering.

The global cancer vaccines market is projected to grow at a CAGR of 9.62% to reach US$9.896 billion by 2024, from US$5.704 billion in 2018.

Global cancer vaccines are either used to protect against cancer or provide treatment. Hence, they are categorized into two types namely prevention and treatment. The growing incidences of cancers worldwide are one of the major market drivers driving the growth of the global cancer vaccines market in the forecast period. Cancer Vaccines are approved for Hepatitis B (HBV) and Human Papilloma Virus (HPV) by FDA. The growing aging population globally may, however, hamper the market growth due to the weak immune system of the elderly population, there are chances where they may be unable to produce an immune response after vaccination.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market.

Major industry players profiled as part of the report are AstraZeneca, GlaxoSmithKline plc., Merck & Co., Inc., Pfizer Inc. and Sanofi among others.

Key Topics Covered:

1. Introduction
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base and Forecast Years Timeline

2. Research Methodology
2.1. Research Design
2.2. Secondary Sources

3. Executive Summary

4. Market Dynamics
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter's Five Force Analysis
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness

5. Global Cancer Vaccines Market by Type
5.1. Prevention
5.2. Treatment

6. Global Cancer Vaccines Market by Application
6.1. Cervical Cancer
6.2. Prostate Cancer
6.3. Others

7. Global Cancer Vaccines Market by Geography
7.1. North America
7.1.1. USA
7.1.2. Canada
7.1.3. Mexico
7.1.4. Others
7.2. South America
7.2.1. Brazil
7.2.2. Argentina
7.2.3. Others
7.3. Europe
7.3.1. Germany
7.3.2. France
7.3.3. United Kingdom
7.3.4. Spain
7.3.5. Others
7.4. Middle East and Africa
7.4.1. Saudi Arabia
7.4.2. Israel
7.4.3. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. Japan
7.5.3. South Korea
7.5.4. India
7.5.5. Others

8. Competitive Intelligence
8.1. Competition and Offerings Analysis of Key Vendors
8.2. Recent Investment and Deals
8.3. Strategies of Key Players

9. Company Profiles
9.1. Astrazeneca
9.2. Glaxosmithkline Plc.
9.3. Merck & Co., Inc.
9.4. Pfizer Inc.
9.5. Sanofi
9.6. Bristol-Myers Squibb
9.7. Moderna, Inc.
9.8. Oncbiomune Pharmaceuticals Inc.
9.9. Maxivax
9.10. Nouscom

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:

SOURCE Research and Markets